Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)
Past Federal grant forecast Posted
- Opportunity number
- RFA-CA-26-011
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
-
- 93.395 Cancer Treatment Research
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
- Other
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute is soliciting applications to fund a single cooperative agreement award to continue the Childhood Cancer Survivor Study (CCSS), a multi-institutional research resource investigating long-term morbidity and mortality associated with cancer treatments; this is a non-competitive funding opportunity limited to the current recipient. Eligible applicants are 501(c)(3) nonprofits and other organizations. The CCSS maintains health-related data from 38,000 or more five-year survivors of pediatric and adolescent cancer patients with a comparison sibling control cohort. The study objectives are to obtain additional age-related longitudinal information from the current cohort and include pediatric cancer survivors receiving modern therapies, serving as a data resource and biorepository for researchers conducting cancer risk assessments, observational and intervention-based research studies, and studies of long-term outcomes across the survivor lifespan with intent to improve cancer treatments. Evaluation emphasizes scientific merit and general significance of proposed study objectives, technical adequacy of experimental design and approach, competency of the proposed investigator team, adequacy of available and proposed facilities and resources, necessity of budget components in relation to the proposed project, and relevance to program objectives. The CCSS operates under CFDA 93.395 (Cancer Treatment Research). This is a forecast notice; specific award amounts, period of performance, and application deadline have not yet been announced.
Forecast synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support the continuation of the Childhood Cancer Survivor Study (CCSS) that investigates the long-term morbidity and mortality associated with cancer treatments. The CCSS represents a multi-institutional, multidisciplinary collaborative research resource that currently has health-related data from 38,000 or more 5-year survivors of pediatric and adolescent cancer patients with a comparison sibling control cohort. This NOFO seeks to obtain additional age-related longitudinal information from the current cohort of survivors and to include pediatric cancer survivors receiving modern therapies. The goal of the CCSS is to serve as a data resource and a biorepository for researchers. The objectives are to use the resources to conduct cancer risk assessments, observational and intervention-based research studies associated with long-term outcomes across the life span of survivors with the intent of improving cancer treatments. This is a Forecast for a single source that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Eligibility
This is a non-competitive funding opportunity intended to fund a single award. Through this single source, cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application to fund a single award to the current recipient of the Childhood Cancer Survivor Study.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity